UK2 Stock Overview
Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Shandong Weigao Group Medical Polymer Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.66 |
| 52 Week High | HK$0.77 |
| 52 Week Low | HK$0.43 |
| Beta | 0.50 |
| 1 Month Change | 8.26% |
| 3 Month Change | 12.93% |
| 1 Year Change | 14.91% |
| 3 Year Change | -28.02% |
| 5 Year Change | -58.01% |
| Change since IPO | 469.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| UK2 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -3.0% | -0.3% | 1.1% |
| 1Y | 14.9% | -9.9% | 16.0% |
Return vs Industry: UK2 exceeded the German Medical Equipment industry which returned -9.3% over the past year.
Return vs Market: UK2 matched the German Market which returned 15% over the past year.
Price Volatility
| UK2 volatility | |
|---|---|
| UK2 Average Weekly Movement | 8.7% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: UK2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: UK2's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 12,719 | Rinan Cong | www.weigaogroup.com |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and orthopedic products comprise spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables.
Shandong Weigao Group Medical Polymer Company Limited Fundamentals Summary
| UK2 fundamental statistics | |
|---|---|
| Market cap | €3.06b |
| Earnings (TTM) | €253.76m |
| Revenue (TTM) | €1.61b |
Is UK2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UK2 income statement (TTM) | |
|---|---|
| Revenue | CN¥13.09b |
| Cost of Revenue | CN¥6.55b |
| Gross Profit | CN¥6.54b |
| Other Expenses | CN¥4.47b |
| Earnings | CN¥2.07b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.45 |
| Gross Margin | 49.94% |
| Net Profit Margin | 15.79% |
| Debt/Equity Ratio | 15.8% |
How did UK2 perform over the long term?
See historical performance and comparisonDividends
Does UK2 pay a reliable dividends?
See UK2 dividend history and benchmarks| Shandong Weigao Group Medical Polymer dividend dates | |
|---|---|
| Ex Dividend Date | Jun 02 2025 |
| Dividend Pay Date | Jul 11 2025 |
| Days until Ex dividend | 12 days |
| Days until Dividend pay date | 51 days |
Does UK2 pay a reliable dividends?
See UK2 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 09:39 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Weigao Group Medical Polymer Company Limited is covered by 33 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Mann | Barclays |
| Derrick Sun | BNP Paribas Securities (Asia) |
| Jessica Li | BofA Global Research |